Emerging immunotherapy targets in lung cancer

por Zhu, Hao-Hua, Feng, Yu, Hu, Xing-Sheng
Publicado 2020

Risk factors associated with acute respiratory distress syndrome in COVID-19 patients outside Wuhan: A double-center retrospective cohort study of 197 cases in Hunan, China

por Hu, Xing-Sheng, Hu, Chun-Hong, Zhong, Ping, Wen, Ya-Jing, Chen, Xiang-Yu
Publicado 2021

Safety, tolerability, and pharmacokinetics of simotinib, a novel specific EGFR tyrosine kinase inhibitor, in patients with advanced non-small cell lung cancer: results of a phase I...

por Hu, Xing-Sheng, Han, Xiao-Hong, Yang, Sheng, Li, Ning, Wang, Lin, Song, Yuan-Yuan, Mu, Hua, Shi, Yuan-Kai
Publicado 2019

Diagnostic accuracy of transient elastography (FibroScan) in detection of esophageal varices in patients with cirrhosis: A meta-analysis

por Pu, Ke, Shi, Jing-Hong, Wang, Xu, Tang, Qian, Wang, Xin-Jie, Tang, Kai-Lin, Long, Zhong-Qi, Hu, Xing-Sheng
Publicado 2017

Rechallenge pemetrexed-based chemotherapy provides an option for initially benefited patients with advanced lung adenocarcinoma

por Wang, Jia-Ni, Qiao, Quan-Hui, Hu, Xing-Sheng, Liu, Yu-Tao, Wang, Zhi-Jie, Duan, Jian-Chun, Feng, Yu, Zhu, Hao-Hua
Publicado 2021

Efficacy of dacomitinib in patients with non-small cell lung cancer carrying complex EGFR mutations: a real-world study

por Li, Hong-Shuai, Li, Jun-Ling, Yan, Xiang, Xu, Hai-Yan, Zhou, Li-Qiang, Hu, Xing-Sheng, Wang, Yu-Ying, Lei, Si-Yu, Wang, Yan
Publicado 2022

Circulating tumor cells (CTCs)/circulating tumor endothelial cells (CTECs) and their subtypes in small cell lung cancer: Predictors for response and prognosis

por Zhu, Hao‐Hua, Liu, Yu‐Tao, Feng, Yu, Zhang, Li‐Na, Zhang, Tong‐Mei, Dong, Gui‐Lan, Xing, Pu‐Yuan, Wang, Hong‐Yu, Shi, Yuan‐Kai, Hu, Xing‐Sheng
Publicado 2021

Survival of patients with advanced lung adenocarcinoma before and after approved use of gefitinib in China

por Liu, Yu-Tao, Hao, Xue-Zhi, Li, Jun-Ling, Hu, Xing-Sheng, Wang, Yan, Wang, Zi-Ping, Wang, Hong-Yu, Wang, Bin, Han, Xiao-Hong, Zhang, Xiang-Ru, Shi, Yuan-Kai
Publicado 2015

Dacomitinib for Advanced Non-small Cell Lung Cancer Patients Harboring Major Uncommon EGFR Alterations: A Dual-Center, Single-Arm, Ambispective Cohort Study in China

por Li, Hong-Shuai, Yang, Guang-Jian, Cai, Yi, Li, Jun-Ling, Xu, Hai-Yan, Zhang, Tao, Zhou, Li-Qiang, Wang, Yu-Ying, Wang, Jin-Liang, Hu, Xing-Sheng, Yan, Xiang, Wang, Yan
Publicado 2022

Depth of Response was Associated with Progression-Free Survival in Patients with Advanced Non-small Cell Lung Cancer treated with EGFR-TKI

por Liu, Yu-Tao, Zhang, Kai, Li, Cheng-Cheng, Hu, Xing-Sheng, Jiang, Jun, Hao, Xue-Zhi, Wang, Yan, Li, Jun-Ling, Xing, Pu-Yuan, Yang, Sheng, Zhang, Xin, Wang, Guo-Qiang, Cai, Shang-Li, Shi, Yuan-Kai
Publicado 2019

Afatinib and Dacomitinib Efficacy, Safety, Progression Patterns, and Resistance Mechanisms in Patients with Non-Small Cell Lung Cancer Carrying Uncommon EGFR Mutations: A Comparati...

por Li, Hong-Shuai, Wang, Shou-Zheng, Xu, Hai-Yan, Yan, Xiang, Zhang, Jin-Yao, Lei, Si-Yu, Li, Teng, Hao, Xue-Zhi, Zhang, Tao, Yang, Guang-Jian, Zhou, Li-Qiang, Liu, Peng, Wang, Yu-Ying, Hu, Xing-Sheng, Xing, Pu-Yuan, Wang, Yan
Publicado 2022

Survival and pretreatment prognostic factors for extensive‐stage small cell lung cancer: A comprehensive analysis of 358 patients

por Huang, Li‐Ling, Hu, Xing‐Sheng, Wang, Yan, Li, Jun‐Ling, Wang, Hong‐Yu, Liu, Peng, Xu, Jian‐Ping, He, Xiao‐Hui, Hao, Xue‐Zhi, Jiang, Pei‐Di, Liu, Yu‐Tao, Luo, Jian, Zhou, Sheng‐Yu, Wang, Jin‐Wan, Yang, Jian‐Liang, Qin, Yan, Yuan, Peng, Lin, Lin, Shi, Yuan‐Kai
Publicado 2021